by David Hamlin | Aug 22, 2018 | News
STRIDE STUDY A Study in Subjects With LOPD Who Are Currently Being Treated With ERT VAL-1221 for Pompe Disease VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Patients With Late-Onset Pompe Disease neoGAA ...
